(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ELIXCYTE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ELIXCYTE

ST13

US500000086261251

Class

5

Filing

86261251

Registration

4690007

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

03/26/2025

Trademark type

Word

Nice classes

5

Filing date

04/24/2014

Registration date

02/17/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/04/2025

Last transaction

03/26/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/03/2014

First use in commerce

04/03/2014

Drawing code

4

Owner type

03

Owner location

Taipei City, TW

Examiner

CRENNAN, KEVIN

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

UNICOCELL BIOMED CO., LTD.
ISIS BIOMED CO. LTD.

Representatives

Justin King WPAT, PC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for medicalpharmaceuticalbiopharmaceutical and biological purposesfor human transplantation or implantationtreatmentreconstruction and repair of connective tissueepithelial tissuemuscle tissuenervous tissue; human allograft cells for medical purposes; human allograft tissue; human allogeneic cells for medical purposes; human allogeneic tissue; human autograft cells for medical purposes; human autograft tissue; human autologous cells for medical purposes; human autologous tissue; stem cells for medical purposes; medicinal preparations for stimulating hair growth; medicated hair care preparations; surgical implants comprising living tissue and cells; biological tissue and cell cultures for medical purposes; medical dressings; wadding for dressings

Publications

History of USPTO decisions and trademark events.

45 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/04/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/04/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/04/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/04/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

10/30/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/25/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/25/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

09/25/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/25/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/25/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/25/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/25/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/17/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/23/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/23/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/30/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/30/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/30/2020

E815

TEAS SECTION 8 & 15 RECEIVED

08/04/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/17/2020

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/03/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/05/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

02/17/2015

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/15/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/14/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/14/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/12/2015

IUAF

USE AMENDMENT FILED

11/29/2014

EISU

TEAS STATEMENT OF USE RECEIVED

11/29/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/25/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/30/2014

PUBO

PUBLISHED FOR OPPOSITION

09/30/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/10/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/27/2014

ALIE

ASSIGNED TO LIE

08/21/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/13/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

08/13/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/13/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

08/13/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/13/2014

DOCK

ASSIGNED TO EXAMINER

08/06/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/07/2014

NWAP

NEW APPLICATION ENTERED

04/28/2014

Continuous trademark protection

Get notified about every new filing that threatens ELIXCYTE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.